Trial Profile
A Phase I Dose Finding Study of Intranasal Oxytocin in Frontotemporal Dementia, Protocol # FTDOXY10EF
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Dementia
- Focus Adverse reactions
- 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jul 2011 New trial record